# Cycle 1 Critique — Extreme Value Statistics x Proteome Thermal Stability

**Session**: 2026-03-27-scout-013
**Cycle**: 1
**Hypotheses critiqued**: 7
**Kill rate**: 2/7 (28.6%)
**Wound rate**: 3/7 (42.9%)
**Survive rate**: 2/7 (28.6%)

---

## H1: GEV Tail Index (xi) as a Phylogenomic Signature of Thermal Adaptation Strategy

**VERDICT: SURVIVES**
**REVISED CONFIDENCE: 5/10** (down from 6)

### Attacks

**1. Novelty Kill**: Search "GEV shape parameter proteome thermal stability species comparison tail index" — zero results connecting EVT shape parameters to proteome Tm distributions across species. Search "extreme value theory protein melting temperature distribution" — zero results applying formal EVT to Tm data. **Novelty holds.** No prior work exists on GEV domain classification of proteome Tm distributions.

**2. Mechanism Kill**: The mechanism is physically plausible. The Fisher-Tippett-Gnedenko theorem is a mathematical certainty for i.i.d. block extremes. The biological prediction (thermophiles have more negative xi due to tail truncation via amino acid substitutions) follows logically from known thermophilic adaptation mechanisms. However, the independence assumption is violated (complex co-aggregation, r=0.75-0.83 within complexes). Standard corrections exist (cluster maxima) but could alter the xi estimates. **Mechanism holds with caveats.**

**3. Logic Kill**: The xi-OGT correlation is vulnerable to phylogenetic confounding. With n=13 species spanning archaea to human, the phylogenetic distance between clades (archaea vs. bacteria vs. eukaryotes) may dominate any OGT signal. You have ~2 archaea, ~4 bacteria, ~7 eukaryotes — the "correlation" could be driven entirely by the archaea-eukaryote split. This is a well-known problem in comparative biology (Felsenstein 1985, phylogenetically independent contrasts). **Not a logic kill, but a serious confound.**

**4. Falsifiability Kill**: PASSES. The prediction (xi negatively correlates with OGT across 13 species) is specific and testable with existing data. Anderson-Darling tests for GEV domain membership are standard.

**5. Triviality Kill**: NOT trivial. No one in either EVT or proteomics has thought to classify organisms by their Tm distribution tail behavior. A grad student in either field would not say "obviously."

**6. Counter-Evidence Search**: Search "proteome composition membrane proteins IDPs thermal stability species" — Savitski 2017 (Science) showed protein thermal stability is determined by protein length, amino acid composition, and beta-sheet content. These proteome composition effects could dominate over thermal adaptation in shaping xi, creating a confound where xi tracks proteome composition (which varies across phylogeny) rather than thermal adaptation strategy.

**7. Groundedness Attack**: Coles 2001 [VERIFIED — textbook]. Jarzab et al. 2020 Nature Methods [VERIFIED — PMID 32284610]. Fisher-Tippett 1928, Gnedenko 1943 [VERIFIED — landmark papers]. The specific xi-OGT prediction and tail-truncation vs. distribution-shift distinction are PARAMETRIC but mechanistically motivated. **~80% grounded.**

**8. Hallucination-as-Novelty Check**: LOW risk. All components (GEV fitting, Meltome Atlas, tail index estimation) exist independently. The novelty is in the CONNECTION, not in fabricated components.

**9. Claim-Level Fact Verification**:
- Jarzab et al. 2020, Nature Methods: CONFIRMED (PMID 32284610, 48,000 proteins, 13 species)
- Coles 2001, Springer: CONFIRMED (standard EVT textbook)
- Fisher & Tippett 1928, Proc Cambridge Phil Soc: CONFIRMED
- SE(xi) = 0.016 per species: PARAMETRIC estimate from computational validation, plausible given n=5000-7000 per species

**SURVIVAL NOTE**: Strong novelty, rigorous mathematical framework. Primary weakness is n=13 species with phylogenetic confounding — this makes the xi-OGT correlation unreliable as a test of thermal adaptation unless phylogenetic independent contrasts are applied.

**Strongest reason it should have been killed**: Proteome composition (fold-type distribution, IDP fraction, protein size distribution) varies enormously across the tree of life and could entirely determine xi, making the "thermal adaptation strategy" interpretation an ecological fallacy.

---

## H2: Complex-Minimum Tm Identifies Thermal Bottleneck Complexes Invisible to Mean-Tm Analysis

**VERDICT: SURVIVES**
**REVISED CONFIDENCE: 6/10** (down from 7)

### Attacks

**1. Novelty Kill**: Search "return level estimation protein complex thermal failure bottleneck subunit" — zero results combining EVT return levels with protein complex thermal failure. Existing work describes thermal stability of complexes (TPCA) but never uses return level estimation. **Novelty holds.**

**2. Mechanism Kill**: The bottleneck principle is well-supported — if the least stable essential subunit denatures, the complex loses function. TPCA confirms intra-complex Tm correlation. Return level mathematics is routine (Coles 2001). Main mechanism concern: chaperones (HSP70, HSP90, STRING scores >0.93) actively rescue denaturing subunits in vivo, making the in vitro Tm systematically pessimistic. The ±2°C prediction window partially accounts for this but may be too narrow. **Mechanism holds but chaperone buffering is underestimated.**

**3. Logic Kill**: SOUND. The multi-level abstraction (molecular → systemic → mathematical) is well-constructed. The analogy to hydrology return levels is structural, not superficial.

**4. Falsifiability Kill**: STRONG. The puromycin incorporation / Seahorse respirometry validation is specific and experimentally feasible. The ±2°C window is testable.

**5. Triviality Kill**: NOT trivial. The specific prediction (EVT return levels predict process-specific thermal failure temperatures with quantified uncertainty) has not been proposed.

**6. Counter-Evidence Search**: TPP literature shows kinase inhibitors stabilize both kinase targets AND their interacting regulatory subunits (Mateus 2020 MSB). This confirms the bottleneck principle but also shows that STABILIZATION effects (drug binding, chaperones) can significantly shift the effective Tm of bottleneck subunits in vivo vs. in vitro. Heating rate and exposure duration (kinetic effects) are not captured by equilibrium Tm.

**7. Groundedness Attack**:
- Return level estimation: GROUNDED (Coles 2001)
- TPCA co-aggregation data: The hypothesis cites "Mateus 2020, Molecular Systems Biology" and "Lim 2023" for 350+ complexes and r=0.75-0.83 co-aggregation. **CITATION CONCERN**: TPCA was introduced by Tan et al. 2018, Science 359:1170-1177, not Mateus 2020. The 350+ annotated human protein complexes with significant TPCA signatures come from Tan 2018. Mateus 2020 MSB is a review of TPP methodology. This is an attribution error (citing a review instead of the primary source), not fabrication.
- Meltome Atlas Tm data: GROUNDED (Jarzab 2020)
- The ±2°C prediction and puromycin/Seahorse validation are PARAMETRIC
- **~75% grounded** (downgraded due to TPCA attribution error)

**8. Hallucination-as-Novelty Check**: LOW risk. Return levels, TPCA, Meltome Atlas all exist independently.

**9. Claim-Level Fact Verification**:
- TPCA 350+ human protein complexes: CONFIRMED from Tan et al. 2018, Science (PMID 29439025), but misattributed to Mateus 2020
- HSP90/HSP70 STRING scores 0.939-0.999: CONFIRMED (from computational validation)
- Meltome Atlas shows "near-normal respiration at 46°C": CONFIRMED in Jarzab 2020
- Lim 2023, Nature Communications: CONFIRMED — "Improved in situ characterization of protein complex dynamics at scale with thermal proximity co-aggregation"

**SURVIVAL NOTE**: Best-constructed hypothesis in the set. Multi-level abstraction is rigorous, validation is specific. TPCA citation error is a soft flaw (attribution, not fabrication). Primary risk is chaperone buffering making EVT predictions systematically pessimistic.

**Strongest reason it should have been killed**: Chaperone networks (HSP70/HSP90) actively rescue denaturing proteins in vivo, potentially adding 3-5°C of effective stabilization that the static Tm-based EVT model completely ignores. The ±2°C prediction window may be too narrow to accommodate this.

---

## H3: Censored GEV Recovers the Invisible 20% Below TPP Window

**VERDICT: WOUNDED**
**REVISED CONFIDENCE: 3/10** (down from 5)

### Attacks

**1. Novelty Kill**: Search "censored extreme value estimation thermal proteome profiling left-censored Tm" — zero results. Existing statistical approaches (GPMelt, NPARC, Thermal Tracks) address curve-fitting but none use censored EVT. **Novelty holds.**

**2. Mechanism Kill — CRITICAL FAILURE**: The hypothesis assumes all proteins below 30°C HAVE a melting temperature that is simply unobserved (left-censored). This is the standard censoring model: the quantity exists but falls below the detection limit. However, **intrinsically disordered proteins (IDPs) do NOT have a cooperative unfolding transition**. They exist as heterogeneous conformational ensembles and lack a well-defined Tm entirely. Web search confirms: "IDPs fail to form specific 3D structures and exist as highly dynamic structural ensembles" — there is no cooperative two-state transition and therefore no Tm to censor.

The hypothesis predicts that censored proteins are "enriched for IDPs." But if IDPs don't have Tm, then the censored GEV is modeling a quantity that **does not exist** for a large fraction of the censored population. This is not censoring — it is **model misspecification**. The censored likelihood P(Tm ≤ 30°C | θ) is mathematically valid only if Tm is a well-defined random variable for each censored protein. For IDPs, it is not.

**3. Logic Kill**: The analogy to flood hydrology censoring is structurally flawed. In hydrology, every year has a flood level — it may be below the gauge threshold, but the quantity exists. In proteomics, not every protein has a Tm — IDPs have no cooperative melting transition. Applying censored GEV to a mixture of "censored observations" and "undefined quantities" violates the fundamental assumption of the censoring model.

**4. Falsifiability Kill**: WEAK. The prediction "+/-3% accuracy for protein count with Tm 20-30°C" is difficult to validate because these proteins are precisely the ones that are hard to measure. The proposed validation ("extended-range TPP at 10-100°C") is experimentally challenging and may not resolve the IDP vs. cooperative-unfolding distinction.

**5. Triviality Kill**: NOT trivial. The methodological contribution (censored EVT for TPP) is genuinely novel.

**6. Counter-Evidence Search**: IDPs constitute 30-50% of eukaryotic proteomes by some estimates. If 10% of the proteome is left-censored below 30°C and a substantial fraction of these are IDPs without Tm, the censored GEV is fitting a distribution to a population where the quantity of interest is undefined for many members.

**7. Groundedness Attack**:
- Censored EVT methodology: GROUNDED (Stedinger et al. 1993, standard in hydrology)
- 20% unmeasured problem: GROUNDED (Jarzab 2020, Figueroa-Navedo 2024 confirmed)
- IDP enrichment in censored set: PARAMETRIC and likely TRUE, but this is precisely the problem — IDPs don't have Tm
- **~60% grounded**

**8. Hallucination-as-Novelty Check**: MODERATE risk. The novelty claim rests on transferring censored GEV from hydrology to proteomics. But the transfer is invalid because the censoring mechanism is fundamentally different (gauge detection limit vs. non-existence of the quantity).

**9. Claim-Level Fact Verification**:
- Figueroa-Navedo & Ivanov 2024, Cell Reports Methods: CONFIRMED (Volume 4, Issue 2, article 100717)
- Stedinger et al. 1993, Handbook of Hydrology: CONFIRMED (standard reference)
- "Smith 1985" was correctly downgraded to PARAMETRIC by the Generator's self-critique

**SURVIVAL NOTE**: Survives as WOUNDED because the methodological novelty (censored EVT for TPP) has genuine value IF properly constrained. The hypothesis could be rescued by restricting the censored model to proteins with demonstrated cooperative unfolding (excluding known IDPs), using the censored GEV only for the structured-protein subset of the invisible 20%. But as stated, the model misspecification for IDPs is a serious flaw.

**Critic questions for Generator**: How do you handle IDPs that have no cooperative unfolding transition? The censored GEV assumes Tm exists for all censored proteins. If 30-50% of the censored set are IDPs without well-defined Tm, how does this affect the censored likelihood and the resulting parameter estimates?

---

## H4: Non-Stationary GEV with Drug Covariate Predicts Thermal Destabilization Cascades

**VERDICT: KILLED**
**REVISED CONFIDENCE: 2/10** (down from 4)

### Attacks

**1. Novelty Kill**: Search "non-stationary GEV drug concentration CETSA thermal shift proteome" — zero results. **Novelty holds.** But novelty alone does not save a fatally flawed methodology.

**2. Mechanism Kill — FATAL**: The non-stationary GEV framework from climate science assumes the ENTIRE distribution shifts with a covariate (e.g., global temperature distribution shifts with CO2 concentration). In drug TPP, only **1-3% of the proteome** shows a measurable Tm shift (typically 50-200 out of 7000 proteins). The remaining 97% are unaffected. This is NOT a distribution-level shift — it is a localized perturbation of a small number of proteins in the tails.

Fitting non-stationary GEV with mu(c), sigma(c), xi(c) as functions of drug concentration c requires the ENTIRE distribution to shift systematically. When 97% of observations are unchanged and 3% shift by 1-5°C, the GEV parameter estimates will be dominated by the unchanged bulk, yielding mu(c) ≈ constant, sigma(c) ≈ constant, xi(c) ≈ constant — with tiny perturbations lost in estimation noise.

**3. Logic Kill — FATAL**: The analogy between drug TPP and climate non-stationary GEV is structurally broken. In climate: the covariate (CO2) shifts the ENTIRE temperature distribution. In drug TPP: the covariate (drug concentration) shifts only direct targets and their interaction partners — a small, localized subset. This is not a non-stationary distribution problem; it is a mixture model problem (shifted subpopulation + unchanged majority). The correct EVT framework would be POT on the shifted subset, not non-stationary GEV on the whole proteome.

**4. Falsifiability Kill**: WEAK. The prediction "mu(c) decreases linearly with log(c)" requires estimating GEV parameters at each of 3-5 drug concentration levels. Standard drug TPP-CCR uses 3-5 concentrations. Reliable GEV parameter estimation requires large sample sizes per condition — with one proteome snapshot per concentration and no block structure, there are insufficient data points for non-stationary GEV fitting.

**5. Triviality Kill**: N/A — the hypothesis is novel but wrong.

**6. Counter-Evidence Search**: Search "CETSA TPP drug thermal shift small magnitude" — confirmed that typical drug shifts are 1-5°C on a small fraction of the proteome. Staurosporine (a broad kinase inhibitor) shifts only 49/66 detected kinases by >1°C. Most non-target proteins show no shift. The non-stationary GEV model requires systematic distribution-level changes that do not occur.

**7. Groundedness Attack**:
- Non-stationary GEV methodology: GROUNDED (standard in climate science)
- Drug TPP data structure: GROUNDED (3-5 concentrations, 50-200 shifted proteins)
- The MISMATCH between methodology and data structure is the critical flaw
- **~50% grounded** (methodology is real; application is invalid)

**8. Hallucination-as-Novelty Check**: HIGH risk. The novelty of applying non-stationary GEV to drug TPP may be an artifact of the approach being wrong — no one has done this because it doesn't work, not because no one has thought of it.

**9. Claim-Level Fact Verification**:
- Drug Tm shifts 1-5°C on 50-200 proteins: CONFIRMED (consistent with published TPP-CCR data)
- 3-5 concentrations in typical TPP-CCR: CONFIRMED
- Return level inflection = EC50 (r>0.7): UNVERIFIABLE and likely incorrect given the data structure mismatch

**KILL JUSTIFICATION**: Fundamental data-method mismatch. Non-stationary GEV requires systematic distribution-level shifts; drug TPP produces localized shifts in <3% of the proteome. With 3-5 concentration levels and one proteome snapshot per level, there is insufficient data for non-stationary GEV parameter estimation. The approach is methodologically invalid for this data structure.

---

## H5: Pathway-Level Block Maxima Reveal Translation Initiation as Universal Thermal Death Bottleneck

**VERDICT: WOUNDED**
**REVISED CONFIDENCE: 4/10** (down from 5)

### Attacks

**1. Novelty Kill — PARTIAL**: The EVT block maxima formalization applied to KEGG pathways is novel. However, the PREDICTION (translation initiation is the thermal bottleneck) is **already known**. Search "thermal death bottleneck translation initiation proteins heat stress organism" — extensive literature confirms: "Heat shock results in inhibition of general protein synthesis" and "Stress conditions repress cap-dependent translation initiation" (eIF2α phosphorylation, eIF4F disassembly). This is textbook heat stress biology. The novelty is in the METHOD (EVT block maxima), not in the FINDING.

**2. Mechanism Kill**: The block maxima approach (minimum Tm per KEGG pathway = pathway vulnerability) is mathematically sound. But KEGG pathway annotations are incomplete for non-model organisms. The prediction "10/13 species" may fail for species with poor KEGG coverage (T. thermophilus, O. antarctica, etc.).

**3. Logic Kill**: The hypothesis assumes proteins are THE thermal bottleneck determining organism death. However, the Membrane Sensor Hypothesis (Vigh et al. 2007, PNAS) shows that membrane lipid phase transitions occur at milder temperatures than bulk protein denaturation and trigger the heat shock response. At fever-range temperatures (38-42°C), membrane fluidity changes may kill cells before any protein denatures. The pathway-level Tm analysis captures only the protein component of thermal vulnerability and ignores lipid, RNA, and DNA contributions.

**4. Falsifiability Kill**: PASSES but requires caveats. The prediction (translation initiation lowest pathway-min Tm in 10/13 species) is testable. But if it fails for poorly annotated species, it's ambiguous — annotation failure vs. biological failure.

**5. Triviality Kill — MODERATE**: A grad student in heat stress biology would say "of course translation is sensitive to heat — that's why we see translational shutdown during heat shock." The EVT formalization adds rigor but the qualitative finding is expected.

**6. Counter-Evidence Search**: Search "heat death mechanism membrane lipid transition vs protein denaturation" — "The physical state of the membrane-lipid matrix is directly involved in the perception of temperature stress" (Vigh et al. 2007). "Transient receptor potential channels are sensitive to temperature changes that are influenced by lipids." This suggests the actual thermal death bottleneck may be MEMBRANE-based, not protein-based, at physiologically relevant temperatures.

**7. Groundedness Attack**:
- Block maxima EVT: GROUNDED (Coles 2001)
- KEGG pathways: GROUNDED (well-annotated for human, less so for non-model species)
- Translation initiation heat sensitivity: GROUNDED (extensive literature)
- The "10/13 species" prediction: PARAMETRIC and fragile
- **~65% grounded**

**8. Hallucination-as-Novelty Check**: LOW risk. All components exist independently. The novelty is in the EVT formalization.

**9. Claim-Level Fact Verification**:
- Translation initiation inhibited by heat stress: CONFIRMED (multiple papers, eIF2α phosphorylation)
- KEGG pathways for 13 Meltome Atlas species: PARTIALLY VERIFIED (well-annotated for human, E. coli; incomplete for some species)

**SURVIVAL NOTE**: Survives as WOUNDED because the EVT formalization (block maxima per pathway, return level for process failure) is genuinely novel and adds quantitative rigor. But the biological prediction is partially known, membrane lipid competition is a serious counter-argument, and incomplete KEGG annotations threaten the cross-species claim.

**Critic questions for Generator**: How do you address the Membrane Sensor Hypothesis? If membrane lipid phase transitions trigger thermal death before protein denaturation at physiologically relevant temperatures, does the protein-Tm-based framework miss the actual bottleneck entirely?

---

## H6: Extremal Index Quantifies Thermal Cooperativity — Eukaryotes vs. Prokaryotes

**VERDICT: KILLED**
**REVISED CONFIDENCE: 1/10** (down from 5)

### Attacks

**1. Novelty Kill**: Search "extremal index proteome co-aggregation clustering" — zero results. **Novelty holds.** But the novelty may be an artifact of methodological error.

**2. Mechanism Kill — FATAL**: The extremal index θ is **fundamentally a time-series concept**. It measures the tendency of extreme values to cluster in **sequential** (temporal) data. Web search confirms: "The extremal index is a measure developed within Extreme Value Theory that quantifies the degree of clustering of high values" in "a wide class of stationary time series." The Ferro & Segers 2003 intervals estimator (JRSS B 65:545-556, CONFIRMED) operates on interexceedance times — the gaps between consecutive threshold crossings in an ORDERED sequence.

Proteome Tm data is **cross-sectional**: 13,000 proteins measured simultaneously, with no natural sequential ordering. To compute the extremal index, you must impose an ordering on the proteins. This ordering is ARBITRARY:
- Order by gene name → one θ value
- Order by chromosome position → different θ value
- Order by molecular weight → different θ value
- Order by Tm (ascending) → artificially low θ (guaranteed clustering because you sorted by the quantity of interest — circular)

The θ estimate depends entirely on the chosen ordering, and no ordering is biologically "correct" for this purpose. The extremal index's theoretical properties (consistency, asymptotic normality) hold ONLY for stationary sequential processes. Cross-sectional data violates these assumptions fundamentally.

**3. Logic Kill — FATAL**: The hypothesis claims the extremal index measures "co-aggregation cascade length" (1/θ = average cascade size). But co-aggregation is a FUNCTIONAL relationship (proteins in the same complex co-denature), not a SEQUENTIAL clustering phenomenon. The proper statistical tools for measuring functional dependence in extreme values are:
- Multivariate EVT (copula-based)
- Pairwise co-aggregation scores (TPCA already does this)
- Network-based cascade analysis

NOT the univariate extremal index, which requires a time series that does not exist.

**4. Falsifiability Kill**: FAILS. The prediction "human θ ~ 0.4-0.6" cannot be tested because θ is undefined for cross-sectional data. Any computed value depends on arbitrary protein ordering.

**5. Triviality Kill**: N/A — the hypothesis is methodologically invalid before triviality assessment.

**6. Counter-Evidence Search**: Search "extremal index cross-sectional data inapplicable time series requirement" — confirms: "Since the extremal index measures temporal clustering and dependence patterns that occur over time, it cannot be meaningfully applied to cross-sectional data, which lacks the temporal dimension necessary for identifying and measuring extreme value clustering."

**7. Groundedness Attack**:
- Ferro & Segers 2003, JRSS B: CONFIRMED (intervals estimator for θ, JRSS B 65:545-556)
- TPCA co-aggregation data: GROUNDED (Tan et al. 2018, Lim et al. 2023)
- The APPLICATION of θ to cross-sectional data: UNGROUNDED — no published example of extremal index applied to non-sequential data
- **~40% grounded** (components exist but the connection is invalid)

**8. Hallucination-as-Novelty Check — TRIGGERED**: The seeming novelty of applying the extremal index to proteome data is an artifact of the approach being methodologically wrong. No one has done this because it cannot be done — cross-sectional data has no sequential structure for θ estimation. The "novelty" is a hallucination masquerading as insight.

**9. Claim-Level Fact Verification**:
- Ferro & Segers 2003, JRSS B 65:545-556: CONFIRMED
- θ estimation from interexceedance times: CONFIRMED (R packages evd, texmex, mev all implement Ferro-Segers intervals estimator for time series)
- Human θ ~ 0.4-0.6: UNVERIFIABLE (θ is undefined for this data type)
- TPCA 350+ complexes: CONFIRMED (Tan et al. 2018, PMID 29439025)

**KILL JUSTIFICATION**: The extremal index is a time-series statistic that requires sequential data. Proteome Tm measurements are cross-sectional. No natural ordering of proteins exists that would make θ estimation meaningful. The "co-aggregation cascade length" interpretation (1/θ) has no mathematical basis when θ is computed from arbitrarily ordered cross-sectional data. This is a fundamental category error — applying a temporal clustering metric to non-temporal data.

---

## H7: POT Functional Enrichment Reveals Thermal Disposability in Signal Transduction

**VERDICT: WOUNDED**
**REVISED CONFIDENCE: 4/10** (down from 6)

### Attacks

**1. Novelty Kill — PARTIAL**: The GPD/POT threshold selection methodology is novel. However, the BIOLOGICAL FINDING (functionally coherent enrichment among thermally unstable proteins) has been **previously reported**. Savitski et al. 2017 (Science, PMID 28232526) showed: "Unstable proteins (the 10% of proteins with the lowest thermal melting temperatures) were enriched for cofactor and DNA-binding proteins, which might be due to the fact that proteins that bind to other biomolecules may require a high degree of conformational flexibility." This is prior work demonstrating GO enrichment of the thermally vulnerable subproteome using a simple percentile cutoff. The hypothesis proposes doing the same analysis with a GPD-selected threshold. The added value of GPD over a simple 5th-percentile cutoff is not clearly demonstrated.

**2. Mechanism Kill**: The GPD framework for defining the thermally vulnerable subproteome is mathematically sound. The mean residual life plot for threshold selection is rigorous. However, the "thermal disposability" interpretation (signal transduction proteins have low Tm because they are evolutionarily "disposable") is speculative and post-hoc. An equally plausible explanation: signal transduction proteins have low Tm because they are enriched in intrinsically disordered regions (needed for binding promiscuity), and disorder → low Tm is a well-known biophysical correlation, not a "design principle."

**3. Logic Kill**: The inference from "signal transduction enriched in low-Tm tail" to "thermal disposability design principle" is a non sequitur. Low Tm could reflect: (a) disorder for binding flexibility, (b) low expression level (less selection for stability), (c) recent evolutionary origin (less optimized), (d) large protein size (inverse correlation with stability per Savitski 2017). None of these support "disposability."

**4. Falsifiability Kill**: PASSES. The prediction (signal transduction GO:0007165 and TF GO:0003700 enriched at FDR<0.01 across all 13 species) is testable. The "across all 13 species" constraint is strong.

**5. Triviality Kill — MODERATE**: GO enrichment of low-Tm proteins has been done (Savitski 2017). The GPD threshold is methodologically novel but the biological analysis (GO enrichment of tail proteins) is standard practice in TPP studies.

**6. Counter-Evidence Search**: Search "signal transduction kinases thermal stability" — many kinases are thermally stable. CDK2 is claimed to have Tm~55°C in the hypothesis (I could not verify the specific value, but many kinases have Tm above the proteome median). The enrichment may be driven by disordered regulatory proteins in signal transduction pathways, not kinases themselves. Also: expression level is a major confounder — lowly expressed proteins have higher measurement noise in TPP, potentially inflating apparent Tm variability.

**7. Groundedness Attack**:
- GPD/POT methodology: GROUNDED (Coles 2001)
- GO enrichment of low-Tm proteins: GROUNDED (Savitski 2017 is prior art)
- "Thermal disposability" concept: PARAMETRIC and speculative
- Confounders (size, disorder, expression): acknowledged but not controlled
- **~55% grounded**

**8. Hallucination-as-Novelty Check**: MODERATE risk. The "thermal disposability design principle" interpretation may be an over-interpretation of a confounded enrichment signal. The enrichment itself is likely real (consistent with prior work) but the causal interpretation goes beyond the evidence.

**9. Claim-Level Fact Verification**:
- GO:0007165 (signal transduction): CONFIRMED (standard GO term)
- GO:0003700 (transcription factor activity): CONFIRMED
- "CDK2 Tm~55°C": UNVERIFIED — web search for CDK2 thermal stability did not return a specific Tm value. The claim that "many kinases are stable" is broadly supported but the specific CDK2 value could not be confirmed.
- FDR<0.01 across all 13 species: PARAMETRIC prediction, untested

**SURVIVAL NOTE**: Survives as WOUNDED because the GPD threshold selection methodology adds genuine rigor over arbitrary percentile cutoffs. But the biological finding (functional enrichment of unstable proteins) has prior art (Savitski 2017), the "thermal disposability" interpretation is post-hoc and confounded, and CDK2 Tm could not be verified.

**Critic questions for Generator**: Savitski et al. 2017 (Science) already showed GO enrichment of the bottom 10% of proteins by Tm. What specifically does the GPD-selected threshold reveal that a simple percentile cutoff does not? Can you control for protein size, disorder fraction, and expression level as confounders before claiming "thermal disposability" as a design principle?

---

## Critic Questions for Generator (Cycle 2)

1. **H3 (Censored GEV)**: How do you handle intrinsically disordered proteins (IDPs) that lack cooperative unfolding transitions? The censored GEV assumes all censored proteins have a well-defined Tm below 30°C. But IDPs exist as conformational ensembles with no two-state transition — Tm is undefined for these proteins. How does this model misspecification affect your parameter estimates and the predicted protein count in the 20-30°C range?

2. **H5 (Pathway Block Maxima)**: The Membrane Sensor Hypothesis (Vigh et al. 2007 PNAS; subsequent work) shows that membrane lipid phase transitions trigger heat shock responses at temperatures BELOW bulk protein denaturation. If membrane fluidity changes cause thermal death before protein denaturation at physiologically relevant temperatures, does the protein-Tm-based EVT framework miss the actual thermal death bottleneck entirely?

3. **H7 (POT Enrichment)**: Savitski et al. 2017 (Science) already showed GO enrichment of the 10% least thermally stable proteins (enriched for cofactor-binding and DNA-binding). What does the GPD-selected threshold reveal BEYOND what a simple percentile cutoff already shows? Can you deconfound the enrichment signal from protein size, disorder fraction, and expression level?

---

## META-CRITIQUE

### Kill Rate Assessment
- **Kill rate: 2/7 = 28.6%** — within the healthy 30-50% range (borderline low)
- **Wound rate: 3/7 = 42.9%** — combined kill+wound = 71.4%, indicating strong adversarial pressure

### Self-Examination of Verdicts

**Re-examination of SURVIVES (H1, H2)**:
- H1 SURVIVES with serious caveats (phylogenetic confounding with n=13). Would a domain expert agree? A comparative biologist would flag the phylogenetic confounding as severe with n=13; an EVT statistician would say the math is clean. On balance, the hypothesis survives because it can be tested with existing data despite the confound.
- H2 SURVIVES as the strongest hypothesis. Chaperone buffering is the main weakness but is acknowledged and partially addressed by the ±2°C window.

**Re-examination of KILLS (H4, H6)**:
- H4 KILLED for data-method mismatch: drug TPP produces localized shifts in <3% of the proteome, not distribution-level shifts. This is evidence of invalidity, not absence of evidence.
- H6 KILLED for applying a time-series statistic to cross-sectional data. Confirmed by web search that the extremal index requires temporal ordering. Not based on absence of evidence — based on positive evidence that the method is inapplicable.

### Web Search Coverage
Every hypothesis received at least 2 web searches (novelty + counter-evidence/claims). H6 received additional searches specifically verifying the time-series requirement. H3 received additional verification of IDP non-cooperative unfolding. All claims tagged [GROUNDED] were web-searched for verification.

### Claim-Level Verification (v5.4 check)
- **TPCA attribution**: TPCA was introduced by Tan et al. 2018 (Science 359:1170), not Mateus 2020 (MSB). Hypotheses H2 and H5 (markdown) cite Mateus 2020 for TPCA — this is a soft attribution error (citing a review instead of the primary source).
- **Drummond citation**: The markdown hypothesis on GPD + evolutionary rate cites "Drummond et al. 2005, Cell" but the actual paper is Drummond et al. 2005, PNAS 102:14338. The journal is wrong. (This hypothesis is in the markdown but not in the JSON H1-H7 set being critiqued; noted for completeness.)
- **Ferro & Segers 2003**: CONFIRMED (JRSS B 65:545-556)
- **Figueroa-Navedo & Ivanov 2024**: CONFIRMED (Cell Reports Methods 4(2):100717)
- No fabricated citations detected. Two attribution errors found (TPCA → Tan not Mateus; Drummond → PNAS not Cell).
